Tue 12/12/2017 22:32 ET
DJIA24504.80118.770.49%SOLAR24.200.291.20%GOLD1245.701.250.10%Shanghai3136.7734.501.10%
S&P 5002664.114.000.15%BANKS28.220.280.99%OIL57.490.500.87%Nikkei22420.08417.011.86%
NASDAQ6862.3213.040.19%SEMI97.630.970.99%US/EU1.170.000.28%Futures2663.254.500.17%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (India Globalization Capital - IGC)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC
  
From: NetworkNewsWire (Rep: 0)Date: 12/07/2017 17:43
Forum: Wall Street Pit - Msg #2705564 - List IGC msgs Thread #673971936 (Rec: 0)
NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites

India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites (www.IGCPharma.com and www.Hyalolex.com) to detail its initiatives, development timeline and pipeline of pharmaceutical cannabinoids for use in treatment of the symptoms of Alzheimer’s disease, pain, seizures and other health-related issues. Ram Mukunda, CEO of IGC, indicated in the news release that Alzheimer’s is IGC’s initial focus on the canna-pharmaceutical front and that the company’s near-term goal is to commercialize its Alzheimer’s liquid formulation as a Complimentary and Alternative Medicine (“CAM”) and sell the product through licensed medical cannabis dispensaries in the U.S., Canada and Germany. Mukunda indicated that longer-term goals include moving IGC’s Alzheimer’s formulation through FDA registered pre-clinical and clinical trials. IGC also has six provisional patent filings for phytocannabinoid-based combination therapy for the indications of pain, medical refractory epilepsy, and cachexia. Further, in May 2017, IGC acquired exclusive rights to a University of South Florida Research Foundation filed patent entitled, “THC as a Potential Therapeutic Agent for Alzheimer’s Disease.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreIGC: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.